newborn screening programme
Biotinidase deficiency
Biotinidase deficiency is one of the inborn errors of metabolism.
Read more about biotidinase deficiency at the Climb National Information Centre for Metabolic Diseases website.
UK NSC screening recommendation
Screening newborns for biotinidase deficiency is not recommended because:
- it is not known how many people in the UK have the condition
- only limited evidence (not from the UK) was found on a range of different screening tests
Supporting documents from the 2022 review
Evidence map
This document investigates whether a more detailed review can be conducted based on the available evidence.
Coversheet
This document summarises the review process including the public consultation comments.
Supporting documents from the 2018 review
In 2018, the UK NSC did not recommend screening for this condition.
Evidence summary Biotinidase deficiency (2018)
This document provides the evidence on which the current UK NSC recommendation is based.
UK NSC coversheet & consultation responses Biotinidase deficiency (2018)
This document summarises the review process including the public consultation comments.
Review cycle
Date previous review completed: 2022
Next review estimated to be completed: 2025 to 2026.
To see previous evidence reviews, visit the UK NSC archive.
Organisations interested in Biotinidase deficiency
These organisations have expressed interest in this recommendation and may submit responses to evidence reviews.
List of organisations
- ArchAngel MLD Trust
- British Association of Perinatal Medicine
- British Inherited Metabolic Disease Group
- Faculty of Public Health
- Genetic Alliance UK
- Metabolic Support UK
- Royal College of General Practitioners
- Royal College of Midwives
- Royal College of Paediatrics and Child Health
- Royal College of Physicians
- Royal College of Physicians and Surgeons of Glasgow
- Royal College of Physicians of Edinburgh
If you think your organisation should be added, please contact us.